PROLIFERATIVE EFFECTS OF CDK4 AND CDK6 DYSREGULATION
PROLIFERATIVE EFFECTS OF CDK4 AND CDK6 DYSREGULATION
批准号:
2024237
负责人:
Philip W. Hinds
金额:
$24.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2002-04-30
关键词:
cell cycle proteins cell growth regulation cell line cell proliferation cell transformation enzyme activity flow cytometry guanine nucleotide binding protein human tissue immunoprecipitation laboratory rat mutant neoplastic transformation northern blottings nucleic acid sequence phosphorylation protein kinase protein structure function tissue /cell culture transfection tumor suppressor proteins western blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: The overall aim of this proposal is to decipher the mechanism
by which overexpression of cdk4/6 overrides p53 and Rb mediated growth. In
this system overexpression of cdk4/6 also leads to overproduction of the
cell cycle inhibitors, p15 and possibly p16. Understanding the mechanism by
which induction of p15 occurs is the first specific aim. The PI will
examine transcriptional and post-transcriptional mechanisms. In addition,
mutants of cdk4/6 that do not bind p15 and p16 will be used in colony
formation assays to determine if the interaction of the kinases with the
inhibitors is essential for overriding p53 mediated growth suppression. The
role of p21 (a target of p53) will also be examined using p21 null cells
overexpressing the temperature sensitive p53 mutant. In aim 2, the
association of cdk4/6 with p15 and p16 will also be examined as the
mechanism by which pRB becomes phosphorylated and thereby inactivated in
this system. The third specific aim will test whether cdk4/6 or mutants
that do not bind p15 and p16 can by themselves promote immortalization and
or transformation of rodent cells. Lastly, the PI will determine if cdk4/6
mutants that are defective in both p15/p16 binding and in hydrolyzing ATP
can function as dominant negative oncogenes. This experiment will help
identify the point in the cell cycle at which p16/p15 function is required
and may aid in identification of substrates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CDK6 in T cell development and cancer
-
批准号:8007389
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:8403614
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:8214597
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7615450
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7846307
-
项目类别:
-
资助金额:$3.82万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
CDK6 in T cell development and cancer
-
批准号:7758353
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2009
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7680551
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7460620
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7105738
-
项目类别:
-
资助金额:$25.75万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7905946
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7893947
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7284828
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:7673449
-
项目类别:
-
资助金额:$24.97万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Regulation and function of cdk5 and ezrin in senescence
-
批准号:8116741
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2006
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7589723
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7264669
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Genetics of RAS, PTEN, BRAF and CDKN2A in Melanoma
-
批准号:7413461
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2005
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:6777135
-
项目类别:
-
资助金额:$42.4万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:6863760
-
项目类别:
-
资助金额:$44.2万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
Cell Cycle Dysregulation in Oral Cancer
-
批准号:7371115
-
项目类别:
-
资助金额:$47.44万
-
财政年份:2004
-
负责人:Philip W. Hinds
-
依托单位:
海外基金